Drug Type Small molecule drug |
Synonyms TBX 2, TBX2 |
Target |
Mechanism MAPKAPK2 inhibitors(MAP kinase-activated protein kinase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 2 | Preclinical | US | 13 May 2021 | |
Diabetes Mellitus, Type 2 | Preclinical | US | 13 May 2021 |